Clinical benefit with SGLT2 inhibitor in diabetes patients with HF independent of ejection fraction
Educational information
This video was recorded at the Congress of the American College of Cardiology (ACC) 2019.
Faculty
Dr. Eri Kato is Cardiologist and researcher at the University of Kyoto in Japan.
Disclosures
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: